Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors
详细信息 查看全文
- 作者：Sheila N. Garlanda ; b ; c ; e ; sheila.garland@mun.ca" class="auth_mail" title="E-mail the corresponding author ; Joseph A. Roscoed ; Charles E. Hecklerd ; Holly Barillac ; Philip Gehrmanc ; James C. Findleyc ; Anita R. Peoplesd ; Gary R. Morrowd ; Charles Kamend ; Michael L. Perlisc ; mperlis@exchange.upenn.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：Cancer ; Insomnia ; Cognitive behavior therapy ; CBT-I ; Armodafinil ; Sleepiness
- 刊名：Sleep Medicine
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：20
- 期：Complete
- 页码：18-24
- 全文大小：569 K
文摘
- •
Cognitive behavior therapy for insomnia (CBT-I) is effective but adherence could be improved.
- •
A wake-promoting medication (armodafinil) may help patients adhere to treatment.
- •
CBT-I, with or without armodafinil, improves sleep continuity and sleepiness in cancer survivors.
- •
Armodafinil did not increase adherence to CBT-I recommendations.
- •
Future efforts should focus on identifying those at risk for poor adherence.